Myriad: NCCN Updates Professional Guidelines for Patients with Prostate Cancer
The Prolaris test from Myriad Genetics was one of only two prognostic tests for prostate cancer recommended by NCCN for the new expanded indications.
Read MoreSearch Results for: prostate cancer
AI System Can Detect and Grade Prostate Cancer
The AI system has the potential to solve one of the bottlenecks in today’s prostate cancer histopathology by providing more accurate diagnosis and better treatment decisions.
Read More
Decipher Prostate RP Improves Postoperative Management and Outcomes for Prostate Cancer Patients
A study showed that when treatment decisions were made and followed based on Decipher Prostate RP genomic test results, patient outcomes were significantly improved.
Read More
Researchers Aim to Create Point-of-Care Biosensor for Prostate Cancer
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read More
Study: Prolaris Test Accurately Predicts Risk of Prostate Cancer Metastases
The study’s objective was to evaluate the ability of the Prolaris test and the Prolaris test combined with clinical information to predict a patient’s 10-year risk of progression to metastatic disease.
Read More